Running for MOMO

Using our strength as a group to do something aside from research. For the Vienna city marathon we decided to run for a viennese organization that supports home care for children with cancer. With the support of several private donors we were able to collect 3000 Euros and certainly drew Read more…

Poster Award

David Pereyra received the best poster award at this years 11th EFR (european federation for colorectal cancer) congress with our work on Osteopontin and its association with disease recurrence after liver resection. TELLvienna congratulates to this great achievement! Great performance and well deserved!

ILC/EASL Updates for HB surgeons

ILC/EASL 2019 Excited to see major interest in our work @ILC2019, EASL in Vienna. Thank you @Medizin Medien Austria for featuring our results and surgical highlights of the congress with an interview – great pleasure. https://medonline.at/innere-medizin/onkologie/krebshilfe/easl-ilc/2019/10028197/easl-ilc-2019-leber-aus-dem-labor-und-weitere-highlights-fuer-chirurgen/

ASO -Author Reflection

Ever found it puzzling that a patient with more than 12 months of neoadjuvant chemotherapy flies trough postoperative recovery after major liver resection without any signs of chemotherapy associated steatohepatitis (CASH) on histology, while some patients after only 2 months of systemic therapy struggle significantly due to chemotherapy associated liver Read more…

Micro RNAs in HB surgery

Remember your last patient developing liver failure after liver resection? Proofs of our recent work on miRNAs in liver surgery are out now demonstrating that miRNAs are sensitive markers for preoperative liver function and predict postoperative outcomes – freely available on: https://lnkd.in/dUq25YG A major step towards personalized medicine in HB Read more…

Non-invasive CASH assessment

Ever found it puzzling that a patient with more than 12 months of neoadjuvant chemotherapy flies trough postoperative recovery after major liver resection without any signs of chemotherapy associated steatohepatitis (CASH) on histology, while some patients after only 2 months of systemic therapy struggle significantly due to chemotherapy associated liver Read more…